The potential approvals of Galderma’s nemolizumab and Eli Lilly’s lebrikizumab are poised to further shift physician perceptions. Preference for the IL-13 mechanism has been steadily declining ...

The CHMP has recommended nemolizumab’s approval for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic ...

ZUG, Switzerland, December 13, 2024--Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of ...

Galderma has received US Food and Drug Administration approval for its monoclonal antibody drug nemolizumab (marketed under the brand name Nemluvio) for the treatment of patients with moderate to ...

The FDA approved Nemluvio (nemolizumab-ilto) to treat adults with prurigo nodularis. The approval was supported by results from the phase 3 OLYMPIA clinical trials.

Nemluvio (nemolizumab-ilto) Interleukin-31 receptor antagonist Treatment of adults and pediatric patients 12 years of age and older with moderate to severe atopic dermatitis in combination with ...

The Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab-ilto) for the treatment of adults with prurigo nodularis.

The FDA and the European Medicines Agency have accepted applications for nemolizumab for the treatment of prurigo nodularis and severe atopic dermatitis in adolescents and adults, Galderma ...

“These results, alongside the OLYMPIA 2 trial data, formed the basis of nemolizumab’s recent U.S. Food and Drug Administration approval for the treatment of adults with prurigo nodularis.

ZUG, Switzerland, August 13, 2024--Galderma today announced that the U.S. Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) as a pre-filled pen for subcutaneous injection ...

Nemluvio (nemolizumab-ilto) Interleukin-31 receptor antagonist Treatment of adults with prurigo nodularis. Nemluvio Approved for Adults With Prurigo Nodularis NexoBrid (anacaulase-bcdb) Bromelain ...